Bb Biotech Ag - Dec 31, 2024 SCHEDULE 13G/A Report for Agios Pharmaceuticals, Inc. Common Stock (AGIO)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Agios Pharmaceuticals, Inc. Common Stock
Symbol: AGIO
Shares outstanding: 56.7M shares
Disclosed Ownership: 3.52M shares
Ownership: 6.2%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 02:35 PM
Date of event: Dec 31, 2024
Next filing: Jun 13, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	6.2%	3.52M	0	3.52M	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Target N.V.	6.2%	3.52M	0	3.52M	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority